4//SEC Filing
Warner Robert Keith 4
Accession 0001209191-23-058376
CIK 0001111485other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:49 PM ET
Size
8.2 KB
Accession
0001209191-23-058376
Insider Transaction Report
Form 4
RxSight, Inc.RXST
Warner Robert Keith
Director
Transactions
- Sale
Common Stock
2023-12-11$35.08/sh−5,498$192,845→ 23,750 total(indirect: See footnote) - Sale
Common Stock
2023-12-08$35.01/sh−14,502$507,706→ 29,248 total(indirect: See footnote)
Holdings
- 27,733
Common Stock
Footnotes (4)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on August 24, 2023 by the Reporting Person.
- [F2]Represents the weighted average share price of an aggregate total of 14,502 shares sold in the price range of $35.00 to $35.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.
- [F4]Represents the weighted average share price of an aggregate total of 5,498 shares sold in the price range of $35.00 to $35.20 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
RxSight, Inc.
CIK 0001111485
Entity typeother
Related Parties
1- filerCIK 0001874373
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:49 PM ET
- Size
- 8.2 KB